A major challenge for distinguishing cancer-causing driver mutations from inconsequential passenger mutations is the long-tail of infrequently mutated genes in cancer genomes. Here, we present and evaluate a method for prioritizing cancer genes accounting not only for mutations in individual genes but also in their neighbors in functional networks, MUFFINN (MUtations For Functional Impact on Network Neighbors). This pathway-centric method shows high sensitivity compared with gene-centric analyses of mutation data. Notably, only a marginal decrease in performance is observed when using 10 % of TCGA patient samples, suggesting the method may potentiate cancer genome projects with small patient populations.This research was partly supported by...
Background: Modern high-throughput genomic technologies represent a comprehensive hallmark of molecu...
A major challenge in interpreting the large volume of mutation data identified by next-generation se...
Genome-wide measurements of genomic state offer unprecedented opportunities for biological discovery...
A major challenge for distinguishing cancer-causing driver mutations from inconsequential passenger ...
Cancers exhibit extensive mutational heterogeneity, and the resulting long-tail phenomenon complicat...
Background: Large-scale cancer genomic projects are providing lots of data on genomic, epigenomic an...
Cancer is a very complex genetic disease driven by combinations of mutated genes. This complexity st...
Abstract Background As one of the deadliest diseases in the world, cancer is driven by a few somatic...
Abstract Background The diversity of genomic alterations in cancer poses challenges to fully underst...
Cancers exhibit extensive mutational heterogeneity and the resulting long tail phenomenon complicate...
Genomic information on tumors from 50 cancer types cataloged by the International Cancer Genome Cons...
A major goal of cancer sequencing projects is to identify genetic alterations that determine clinica...
As the genomic profile across cancers varies from person to person, patient prognosis and treatment ...
Tumor-specific genomic alterations allow systematic identification of genetic interactions that prom...
<div><p>A major challenge in interpreting the large volume of mutation data identified by next-gener...
Background: Modern high-throughput genomic technologies represent a comprehensive hallmark of molecu...
A major challenge in interpreting the large volume of mutation data identified by next-generation se...
Genome-wide measurements of genomic state offer unprecedented opportunities for biological discovery...
A major challenge for distinguishing cancer-causing driver mutations from inconsequential passenger ...
Cancers exhibit extensive mutational heterogeneity, and the resulting long-tail phenomenon complicat...
Background: Large-scale cancer genomic projects are providing lots of data on genomic, epigenomic an...
Cancer is a very complex genetic disease driven by combinations of mutated genes. This complexity st...
Abstract Background As one of the deadliest diseases in the world, cancer is driven by a few somatic...
Abstract Background The diversity of genomic alterations in cancer poses challenges to fully underst...
Cancers exhibit extensive mutational heterogeneity and the resulting long tail phenomenon complicate...
Genomic information on tumors from 50 cancer types cataloged by the International Cancer Genome Cons...
A major goal of cancer sequencing projects is to identify genetic alterations that determine clinica...
As the genomic profile across cancers varies from person to person, patient prognosis and treatment ...
Tumor-specific genomic alterations allow systematic identification of genetic interactions that prom...
<div><p>A major challenge in interpreting the large volume of mutation data identified by next-gener...
Background: Modern high-throughput genomic technologies represent a comprehensive hallmark of molecu...
A major challenge in interpreting the large volume of mutation data identified by next-generation se...
Genome-wide measurements of genomic state offer unprecedented opportunities for biological discovery...